ALXO Forecast


Bullish Case: ALXO has promising clinical results for evorpacept and insider purchase signals confidence, predicting a rise to $25.


Bearish Case: High implied volatility and significant insider selling indicate risk of bearish sentiment, potentially dropping to $14.


Potential Outcomes:

1. Strong clinical results boost to $25 (60%).

2. Insider sales drive price to $14 (20%).

3. Market stabilization at $7-$8 (20%).


Trading Oracle: Trade short-term bullish call debit spreads targeting $9-$12 strikes over the next month. This leverages expected volatility and potential upward momentum. Focus on August options to manage risk and capture movement.


July 18, 2024


Alx Oncology Forecast

ALXO      Alx Oncology











Correlated Assets

Assets that tend to move strongly with ALXO



ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.45)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.07)


LI Forecast + Options Trading Strategies   LI  Li Auto (-0.31)


VFC Forecast + Options Trading Strategies   VFC  VF (-0.43)



Uncorrelated Assets

Assets with little price relationship to ALXO



XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.07)


LI Forecast + Options Trading Strategies   LI  Li Auto (-0.31)


VFC Forecast + Options Trading Strategies   VFC  VF (-0.43)


ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.45)



Anticorrelated Assets

Assets that tend to move strongly against ALXO



ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.45)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.07)


LI Forecast + Options Trading Strategies   LI  Li Auto (-0.31)


VFC Forecast + Options Trading Strategies   VFC  VF (-0.43)





Become a more profitable investor with AI optimized trading strategies






×

Chat with ALXO


 Ask any question about ALXO!